Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats

Hypertension Research

Volumn 37, Issue 2, 2014, Pages 100-109

  Heijnen, Bart F J ^a   Van Essen, Helma ^a   Schalkwijk, Casper G ^a   Janssen, Ben J A ^a   Struijker Boudier, Harry A J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

angiotensin II type 1 receptor; kidney injury molecule 1; renal inflammation; spontaneously hypertensive rat; transient prehypertensive treatment

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BIOLOGICAL MARKER; CD3 ANTIGEN; CD68 ANTIGEN; CYCLOPHILIN A; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; LOSARTAN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; RENIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CREATININE URINE LEVEL; GENE EXPRESSION; HYPERTENSION; KIDNEY INJURY; KIDNEY MASS; MALE; NEPHRITIS; NONHUMAN; PROTEIN URINE LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; URINARY EXCRETION;

ADAPTIVE IMMUNITY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; GENE EXPRESSION; HEMODYNAMICS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TESTS; LOSARTAN; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA;

EID: 84893761526     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.99     Document Type: Article

References (33)

1. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
2. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr., Messerli FH, Oparil S, Schork MA. Feasibility of treating prehyper-tension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685-1697.
3. Baumann M, Janssen BJ, Hermans JJ, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. J Hypertens 2007; 25: 207-215.
4. Baumann M, Megens R, Bartholome R, Dolff S, van Zandvoort MA, Smits JF, Struijker-Boudier HA, De Mey JG. Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function. Hypertens Res 2007; 30: 853-861.
5. Bergstrom G, Johansson I, Wickman A, Gan L, Thorup C. Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure. J Hypertens 2002; 20: 1413-1421.
6. Harrap SB, Mirakian C, Datodi SR, Lever AF. Blood pressure and lifespan following brief ACE inhibitor treatment in young spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1994; 21: 125-127.
7. Luders S, Schrader J, Berger J, Unger T, Zidek W, Bohm M, Middeke M, Motz W, Lubcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens 2008; 26: 1487-1496.
8. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension 2011; 57: 132-140.
9. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006; 21: 16-20.
10. Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 2012; 59: 367-374.
11. Heijnen BFJ, Peutz-Kootstra CJ, Mullins JJ, Janssen BJA, Struijker-Boudier HAJ. Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats. J Hypertens 2011; 29: 2369-2380.
12. Heijnen BF, Nelissen J, van Essen H, Fazzi GE, Cohen Tervaert JW, Peutz-Kootstra CJ, Mullins JJ, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA. Irreversible renal damage after transient ras stimulation: involvement of an at1-receptor mediated immune response. PLoS One 2013; 8: e57815.
13. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31-38.
14. Hultstrom M. Development of structural kidney damage in spontaneously hypertensive rats. J Hypertens 2012; 30: 1087-1091.
15. Baumann M, Bartholome R, Peutz-Kootstra CJ, Smits JF, Struijker-Boudier HA. Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging? Am J Hypertens 2008; 21: 177-182.
16. Baumann M, Janssen BJ, Rob Hermans JJ, Bartholome R, Smits JF, Struijker Boudier HA. Renal medullary effects of transient prehypertensive treatment in young spontaneously hypertensive rats. Acta Physiol (Oxf) 2009; 196: 231-237.
17. Nozaki Y, Nikolic-Paterson DJ, Snelgrove SL, Akiba H, Yagita H, Holdsworth SR, Kitching AR. Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int 2012; 81: 844-855.
18. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND, Nicholas SB. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009; 76: 32-43.
19. Umetsu SE, Lee WL, McIntire JJ, Downey L, Sanjanwala B, Akbari O, Berry GJ, Nagumo H, Freeman GJ, Umetsu DT, DeKruyff RH. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005; 6: 447-454.
20. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis 2010; 17: 469-479.
21. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002; 277: 39739-39748.
22. Lim AI, Tang SC, Lai KN, Leung JC. Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? J Cell Physiol 2012; 228: 917-924.
23. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994; 83: 140-147.
24. Reckelhoff JF, Zhang H, Granger JP. Decline in renal hemodynamic function in aging SHR: role of androgens. Hypertension 1997; 30 (3 Pt 2), 677-681.
25. Gattone VH 2nd, Evan AP, Overhage JM, Severs WB. Developing renal innervation in the spontaneously hypertensive rat: evidence for a role of the sympathetic nervous system in renal damage. J Hypertens 1990; 8: 423-428.
26. Komolova M, Friberg P, Adams MA. Altered vascular resistance properties and acute pressure-natriuresis mechanism in neonatal and weaning spontaneously hypertensive rats. Hypertension 2012; 59: 979-984.
27. Racasan S, Hahnel B, van der Giezen DM, Blezer EL, Goldschmeding R, Braam B, Kriz W, Koomans HA, Joles JA. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Kidney Int 2004; 65: 575-581.
28. Koeners MP, Braam B, Joles JA. Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats. J Hypertens 2011; 29: 1160-1166.
29. Rodriguez-Iturbe B, Quiroz Y, Ferrebuz A, Parra G, Vaziri ND. Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats. Am J Nephrol 2004; 24: 587-594.
30. Baumann M, Stehouwer C, Scheijen J, Heemann U, Struijker Boudier H, Schalkwijk C. N epsilon-(carboxymethyl)lysine during the early development of hypertension. Ann N Y Acad Sci 2008; 1126: 201-204.
31. Murphy TJ, Ni Choileain N, Zang Y, Mannick JA, Lederer JA. CD4 CD25 regulatory T cells control innate immune reactivity after injury. J Immunol 2005; 174: 2957-2963.
32. Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, Nakamura M, Yamazaki S, Enomoto Y, Oki T, Akiba H, Abe T, Komori T, Morikawa Y, Kiyonari H, Takai T, Okumura K, Kitamura T. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med 2010; 207: 1501-1511.
33. Meyers JH, Chakravarti S, Schlesinger D, Illes Z, Waldner H, Umetsu SE, Kenny J, Zheng XX, Umetsu DT, DeKruyff RH, Strom TB, Kuchroo VK. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol 2005; 6: 455-464.